Search the webpage

President, Chief Executive Officer and Director

President, Chief Executive Officer and Director

ABOUT

Dr. Kalesnykas earned his Ph.D. in Neuroscience in 2005 from the University of Kuopio and completed several postdoctoral fellowships studying the pathophysiology of glaucoma and ocular gene therapy.

In 2009, Dr. Kalesnykas was awarded the prestigious position of Finnish Academy Research Fellow, which he held until 2013. He was a visiting researcher at the Wilmer Eye Institute at The Johns Hopkins University from 2010-2011. In 2013, he founded Experimentica Ltd., which under his leadership has grown to become one of the leading preclinical CROs dedicated to drug discovery and development for ophthalmic disorders.

FOLLOW

LATEST NEWS

New Board of Directors announced

News
Experimentica Ltd., a global contract research organization that specializes in preclinical models for ophthalmic diseases, is pleased to announce its ... Read More

New insights to the supporting mechanism of fluid management in the neural retina

News
Angiopoietin-4 was identified as the first growth factor having a venous-specific function in the mouse retina, according to a publication ... Read More

Experimentica Ltd. opens a new R&D site in Lithuania

News
The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI” (project no. 01.2.1-LVPA-T-848-01-005) under the ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!